Patents by Inventor Douglas Clarke

Douglas Clarke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140066516
    Abstract: The present invention is directed to a novel method for reducing intrapatient variability in pharmaceutically active agent which is suitably not absorbed in the stomach, such as paracetamol, containing formulations in patients having gastric dysmotility, or a method of improving analgesia in a diabetic patient, or improving absorption of an active agent is a patient with gastric dysmotility, which methods comprises administering orally to said patient in need thereof a pharmaceutical dosage form comprising a first active agent, calcium carbonate, at least one first binding agent, and at least one disintegrating agent as intragranular components in the form of a granulate, and as an extragranular component at least one hydrophilic colloid, an optionally a second binding agent, calcium carbonate, a super disintegrant, and a second active agent.
    Type: Application
    Filed: November 6, 2013
    Publication date: March 6, 2014
    Applicant: GLAXOSMITHKLINE, LLC
    Inventors: Geoffrey Douglas Clarke, Timothy James Grattan, Ian Burnett
  • Publication number: 20130333278
    Abstract: Low water-containing biomass-derived pyrolysis oils and processes for producing them are provided. The process (200) includes condensing (204) pyrolysis gases including condensable pyrolysis gases and non-condensable gases to separate the condensable pyrolysis gases from the non-condensable gases, the non-condensable gases having a water content, drying (206) the non-condensable pyrolysis gases to reduce the water content of the-non-condensable gases to form reduced-water non-condensable pyrolysis gases, and providing (208) the reduced-water non-condensable pyrolysis gases to a pyrolysis reactor for forming the biomass-derived pyrolysis oil.
    Type: Application
    Filed: July 14, 2011
    Publication date: December 19, 2013
    Applicant: ENSYN RENEWABLES, INC.
    Inventors: Stanley J. Frey, Douglas A. Clarke
  • Patent number: 8604084
    Abstract: The present invention is directed to a novel method for reducing intrapatient variability in pharmaceutically active agent which is suitably not absorbed in the stomach, such as paracetamol, containing formulations in patients having gastric dysmotility, or a method of improving analgesia in a diabetic patient, or improving absorption of an active agent is a patient with gastric dysmotility, which methods comprises administering orally to said patient in need thereof a pharmaceutical dosage form comprising a first active agent, calcium carbonate, at least one first binding agent, and at least one disintegrating agent as intragranular components in the form of a granulate, and as an extragranular component at least one hydrophilic colloid, an optionally a second binding agent, calcium carbonate, a super disintegrant, and a second active agent.
    Type: Grant
    Filed: July 29, 2009
    Date of Patent: December 10, 2013
    Assignee: GlaxoSmithKline, LLC
    Inventors: Geoffrey Douglas Clarke, Timothy James Grattan, Ian Burnett
  • Patent number: 8519205
    Abstract: Low water-containing biomass-derived pyrolysis oils and processes for producing them are provided. The process includes condensing pyrolysis gases including condensable pyrolysis gases and non-condensable gases to separate the condensable pyrolysis gases from the non-condensable gases, the non-condensable gases having a water content, drying the non-condensable pyrolysis gases to reduce the water content of the-non-condensable gases to form reduced-water non-condensable pyrolysis gases, and providing the reduced-water non-condensable pyrolysis gases to a pyrolysis reactor for forming the biomass-derived pyrolysis oil.
    Type: Grant
    Filed: July 23, 2010
    Date of Patent: August 27, 2013
    Assignee: Ensyn Renewables, Inc.
    Inventors: Stanley J. Frey, Douglas A. Clarke
  • Publication number: 20130086118
    Abstract: Generally, an application provider can use their understanding of the general problem domain to design an application that covers the majority of the functionality that is required by application users, e.g., the types and quantities of data that are required by an application and which are typically gathered and stored. By configuring the application with flexible data structures which can be mapped to a variety of different types of data by the application user, the application can be customized by the application user to meet his or her specific needs. When the application user wants to expand the data set that is stored by the application beyond what the application provider has provided, they can make use of a management interface to add mappings for custom attributes to the flexible data structures. The application users are not required to write any additional code or modify the application directly.
    Type: Application
    Filed: December 20, 2011
    Publication date: April 4, 2013
    Applicant: ORACLE INTERNATIONAL CORPORATION
    Inventors: Thomas Ware, Douglas Clarke, Chris Delahunt
  • Publication number: 20130086119
    Abstract: In an EclipseLink environment, persistence units are associated with a single data source. However, in accordance with an embodiment, a user can define multiple persistence units, each with a different set of entity types (i.e., classes) stored in multiple data sources, and expose them through a single composite persistence unit which combines the entities from across the multiple data sources through a single persistence context. A plurality of different types of data sources can be used, including Java Transaction API (JTA) and non-JTA data sources as well as EclipseLink's native JDBC connection pools. Each member persistence unit continues mapping its classes to its own data source. Therefore, a composite persistence unit allows one to map different entities to different data sources. Composite persistence units can be created at runtime.
    Type: Application
    Filed: December 20, 2011
    Publication date: April 4, 2013
    Applicant: ORACLE INTERNATIONAL CORPORATION
    Inventors: Andrei Ilitchev, James Sutherland, Douglas Clarke
  • Publication number: 20130086322
    Abstract: Systems and methods are provided to support multitenant data in an EclipseLink environment. EclipseLink supports shared multitenant tables using tenant discriminator columns, allowing an application to be re-used for multiple tenants and have all their data co-located. Tenants can share the same schema transparently, without affecting one another and can use non-multitenant entity types as per usual. This functionality is flexible enough to allow for its usage at an Entity Manager Factory level or with individual Entity Manager's based on the application's needs. Support for multitenant entities can be done though the usage of a multitenant annotation or <multitenant> xml element configured in an eclipselink-orm.xml mapping file. The multitenant annotation can be used on an entity or mapped superclass and is used in conjunction with a tenant discriminator column or <tenant-discriminator-column> xml element.
    Type: Application
    Filed: December 20, 2011
    Publication date: April 4, 2013
    Applicant: ORACLE INTERNATIONAL CORPORATION
    Inventors: Guy Pelletier, Douglas Clarke
  • Publication number: 20130086134
    Abstract: Systems and methods are provided for automatically provisioning resources based on application characteristics. In accordance with an embodiment, a system can include a computer, including a computer readable medium and processor. The system can further include one or more servers executing on the computer and an extensible application deployed to the one or more servers, wherein the application includes a plurality of real properties. A plurality of tenants can each utilize the application at the one or more servers. The extensible application is configured to be customized for each tenant, wherein customizing includes for each tenant, defining one or more virtual properties for the application in a metadata file, and mapping the one or more virtual properties to the application using the metadata file.
    Type: Application
    Filed: December 20, 2011
    Publication date: April 4, 2013
    Applicant: ORACLE INTERNATIONAL CORPORATION
    Inventors: Blaise Doughan, Douglas Clarke
  • Publication number: 20130014155
    Abstract: Disclosed herein is a system and method for rendering media related content and web services. According to one or more embodiments, media content is rendered from a source. In one or more segments of the media source, at least one of an object, person or location is identified and additional information, relevant content or services about the person, object or location are displayed or made accessible while or after the media content is being rendered, on one or more devices and/or on one or more paired devices.
    Type: Application
    Filed: June 14, 2012
    Publication date: January 10, 2013
    Inventors: Douglas Clarke, Michael Dalrymple, Edward Lee Elliott, John Fox, Mark Johnson, Darren Lepke, Thomas Purnell-Fisher, Herve Utheza
  • Publication number: 20110301243
    Abstract: The present invention is directed to a novel method for reducing intrapatient variability in pharmaceutically active agent which is suitably not absorbed in the stomach, such as paracetamol, containing formulations in patients having gastric dysmotility, or a method of improving analgesia in a diabetic patient, or improving absorption of an active agent is a patient with gastric dysmotility, which methods comprises administering orally to said patient in need thereof a pharmaceutical dosage form comprising a first active agent, calcium carbonate, at least one first binding agent, and at least one disintegrating agent as intragranular components in the form of a granulate, and as an extragranular component at least one hydrophilic colloid, an optionally a second binding agent, calcium carbonate, a super disintegrant, and a second active agent.
    Type: Application
    Filed: July 29, 2009
    Publication date: December 8, 2011
    Inventors: Geoffrey Douglas Clarke, Timothy James Grattan, Ian Burnett
  • Patent number: 7872051
    Abstract: The use of p-menthane-3,8-diol (PMD) in the manufacture of a medicament for use as an antiviral agent. The use of PMD in the manufacture of a medicament to destroy or inactivate viruses. The use of PMD, in vitro, as an antiviral or virucidal agent. The use of PMD in the manufacture of a medicament for the treatment of diseases caused by viruses having a lipid envelope. A face mask comprising at least one protective layer impregnated or sprayed with PMD.
    Type: Grant
    Filed: March 2, 2005
    Date of Patent: January 18, 2011
    Inventor: Paul Douglas Clarke
  • Patent number: 7396547
    Abstract: p-Menthane-3,8-diol (PMD) has antiseptic, antibiotic, fungicidal and bactericidal properties. It is used for these purposes in the form of compositions and method comprising the PMD and optionally a carrier. A method of treating acne, folliculitis body, scalp folliculitis, Hydradinitis suppuritiva dandruff, seborrhoeic dermatitis (scalp or body), pityriasis versicolor, pityrosporun folliculitis, tinea corporis, tinea pedis, tinea cruris, tinea capitis, tinea unguum, tinea folliculitis or rosacea in a patient including administering an effective amount of PMD.
    Type: Grant
    Filed: January 30, 2007
    Date of Patent: July 8, 2008
    Inventor: Paul Douglas Clarke
  • Patent number: 7199153
    Abstract: A formulation is described comprising paracetamol, niflumic acid or a pharmaceutically acceptable salt or ester thereof and a pharmaceutically acceptable excipient.
    Type: Grant
    Filed: March 20, 2001
    Date of Patent: April 3, 2007
    Assignee: SmithKline Beechman, p.l.c.
    Inventors: Geoffrey Douglas Clarke, Melanie Jayne Sammons, Mark Wyles
  • Patent number: 7189421
    Abstract: p-Menthane-3,8-diol (PMD) has antiseptic, antibiotic, fungicidal and bactericidal properties. It is used for these purposes in the form of compositions and method comprising the PMD and optionally a carrier. A method of treating acne, folliculitis body, scalp folliculitis, Hydradinitis suppuritiva dandruff, seborrhoeic dermatitis (scalp or body), pityriasis versicolor, pityrosporun folliculitis, tinea corporis, tinea pedis, tinea cruris, tinea capitis, tinea unguum, tinea folliculitis or rosacea in a patient including administering an effective amount of PMD.
    Type: Grant
    Filed: September 23, 2005
    Date of Patent: March 13, 2007
    Inventor: Paul Douglas Clarke
  • Patent number: 6925732
    Abstract: The invention is an article of footwear with an upper and a sole structure. The primary components of the sole structure are a midsole and a frame element. The midsole is connected to the upper in a forefoot region of the footwear, but is unconnected to the upper in a rearfoot region of the footwear. The frame element is structured to extend onto a heel portion of the upper and around the heel portion to thereby stabilize the heel portion. The frame element may serve as a spring that provides cushioning in combination with the midsole. The configuration of the frame element, which extend onto the heel portion of the upper, leaves a lower surface of the upper exposed to permit direct contact with the midsole.
    Type: Grant
    Filed: June 19, 2003
    Date of Patent: August 9, 2005
    Assignee: Nike, Inc.
    Inventor: Richard Douglas Clarke
  • Publication number: 20040247708
    Abstract: p-Menthane-3,8-diol (PMD) has antiseptic, antibiotic, fungicidal and bactericidal properties. It is used for these purposes in the form of compositions comprising the PMD and a carrier.
    Type: Application
    Filed: July 9, 2004
    Publication date: December 9, 2004
    Inventor: Paul Douglas Clarke
  • Publication number: 20040010044
    Abstract: A formulation is described comprising paracetamol, niflumic acid or a pharmaceutically acceptable salt or ester thereof and a pharmaceutically acceptable excipient.
    Type: Application
    Filed: June 6, 2003
    Publication date: January 15, 2004
    Inventors: Geoffrey Douglas Clarke, Melanie Jayne Sammons, Mark Wyles
  • Publication number: 20020153488
    Abstract: Described is a manner of determining the three-dimensional direction of a radiating source. The system uses two pairs of coplanar solid-state radiation detectors perpendicularly arranged. The three-dimensional direction of the radiating source is found through the use of suitably positioned walls or absorbers of the radiation. The lengths of the shadows cast by the walls leads to a change in incident radiation detected by the various detectors. A ratio of the detected incident radiation is uniquely and simply related to the angle of the source in three dimensions. When the three-dimensional direction of the object is determined from two points, the distance to the object from each of the points is calculated using triangulation. A glove having one or more LEDs, uses the system to detect the three-dimensional position of each LED, and the three-dimensional positions of the LEDs are used to determine yaw, pitch and roll.
    Type: Application
    Filed: March 7, 2002
    Publication date: October 24, 2002
    Inventors: Avanindra Utukuri, Jonathan Douglas Clarke, Kumar Utukuri
  • Patent number: 5754287
    Abstract: A plumb apparatus is described in two embodiments having common operational and construction features. In a first embodiment, a beam projector is mounted within an upper end of an elongate pipe which is slidingly fit in an angularly pivotable mounting. The lower end of the pipe is formed with a point adapted to contact a target point on a supporting surface when a base in which the angularly pivotable mounting is held is placed on the surface. A bi-axial level is attached to the upper end of the pipe to ascertain vertical orientation of the pipe, which orientation is maintained by the weight of the base structure which is in contact with the supporting surface. The beam projector is activated to project a beam to a target point on the ceiling above. According to the second preferred embodiment, a beam projector is mounted into an upper end of a pipe, the lower end of which is mounted into a ball. The ball is placed into a cup which is engaged by a clamp cover having an opening through which the pipe extends.
    Type: Grant
    Filed: January 6, 1997
    Date of Patent: May 19, 1998
    Inventor: Douglas A. Clarke